Search

Issue
Title
Authors
Vol 13, No 4 (2023)
“Watch and wait” approach in the treatment of advanced radioiodine refractory differentiated thyroid cancer: a study of barriers and drivers of use
Borodavina E.V., Shurinov A.Y., Kutukova S.I., Nedozorova E.N., Malanchuk A.V., Semenchenko Y.V., Povarkov S.M., Narovenkova K.V., Khodkevich A.V., Komoza Y.V., Kofanova K.A., Dmitriev S.P., Vasilyeva E.B., Shikhamirova S.A., Gorshenina M.N., Volodina L.N., Snezhko O.A., Stativko O.A., Xenodokhov D.V., Dzhemageldieva Y.G., Khryapa A.I., Ulimaeva D.M., Dagba E.M., Volkonsky M.V., Filippova V.M., Skorina M.O., Romanchuk O.V., Andrienko I.I., Shorin M.V., Ishchenko A.A., Dumbrava R.A., Bolieva M.B., Tsarakhova F.V., Gojieva Z.A., Dzhamirzaeva S.S., Aidaeva P.Z., Maximov M.O., Usoltseva I.S., Milyukova A.O., Toporkova O.V., Sychev V.D., Rudakov S.A., Sagdieva S.T., Klochikhin M.A., Molokova V.V., Skotnikov R.A., Yeremina E.N., Panaseikin Y.A., Tyugina Y.A., Murzina Y.I., Podvyaznikov S.O.
PDF
(Rus)
Vol 15, No 1 (2025)
Selpercatinib in the treatment of medullary and radioiodine-refractory differentiated thyroid cancer with RET mutation (literature review)
Borodavina E.V., Kutukova S.I., Kekeeva Т.V., Isaev Р.A.
PDF
(Rus)
Vol 5, No 2 (2015)
New-generation mutitargeted tyrosine kinase inhibitors in the treatment of radioactive iodine-refractory differentiated thyroid cancer
Mudunov A.M.
PDF
(Rus)
Vol 14, No 2 (2024)
Observation and treatment of patients with progressive metastatic differentiated thyroid cancer after establishment of radioiodine refractoriness
Borodavina E.V., Kutukova S.I., Shurinov A.Y., Vasil’eva E.B., Guz A.O., Grishkevich I.V., Karateeva S.D., Shakhmatova A.R., Slobodyanskiy R.S., Romanchuk O.V., Mukhitova M.R., Karpovich M.P., Dmitriev S.P., Saypeeva O.S., Tolpeykina K.A., Tolstov S.S., Makarova A.V., Tyugina Y.A., Ovchinnikova E.G.
PDF
(Rus)
Vol 12, No 1 (2022)
A randomized study to evaluate the safety and efficacy of two dosages of lenvatinib – 18 and 24 mg – in patients with radioiodrefract differentiated thyroid cancer
Brose M.S., Panaseykin Y., Konda B., de la Fouchardiere C., Hughes B.G., Gianoukakis A.G., Park Y.J., Romanov I., Krzyzanowska M.K., Leboulleux S., Binder T.A., Dutcus C., Xie R., Taylor M.H.
PDF
(Rus)
Vol 11, No 3 (2021)
Personalized therapy with lenvatinib for progressive radioiodine refractory differentiated thyroid cancer in routine clinical practice
Rumyantsev P.O., Borodavina E.V., Kutukova S.I., Vasilyeva E.B.
PDF
(Rus)
Vol 8, No 3 (2018)
Prolonged duration of response in lenvatinib responders with thyroid cancer (Russian translation)
Gianoukakis A.G., Dutcus C.E., Batty N., Guo M., Baig M.
PDF
(Rus)
Vol 8, No 2 (2018)
Effect of age on the efficacy and safety of lenvatinib in radioiodine-refractory differentiated thyroid cancer in the phase III SELECT Trial
Brose M.S., Worden F.P., Newbold K.L., Guo M., Hurria A.
PDF
(Rus)
Vol 15, No 1 (2025)
Advanced metastatic radioiodine refractory differentiated thyroid cancer: current treatment and dynamic surveillance issues
Borodavina E.V., Shurinov A.Y., Krylov V.V.
PDF
(Rus)
Vol 14, No 4 (2024)
Lenvatinib in advanced radioiodine-refractory differentiated thyroid cancer: what’s new?
Borodavina E.V., Kutukova S.I., Shurinov A.Y., Krylov V.V.
PDF
(Rus)
1 - 10 of 10 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"